The Importance of Mutational Analysis in Chronic Myeloid Leukaemia for Treatment Choice
Since their introduction in 2001, tyrosine kinase inhibitors (TKIs) targeting BCR-ABL have become the standard therapy for chronic myeloid leukaemia (CML). While allogeneic hematopoietic stem cell transplant is a recognised curative treatment for CML, TKIs prevent progression to advanced phase in mo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2016-11-01
|
| Series: | European Medical Journal Oncology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/oncology/article/the-importance-of-mutational-analysis-in-chronic-myeloid-leukaemia-for-treatment-choice/ |